38832. Interactive Panelist
Session: Interactive Session: Direct Acting Antivirals for HCV: State-of-the-Art
Friday, October 19, 2012: 3:30 PM
Room: Ballroom 20 ABCD
David Thomas, MD, MPH, FIDSA, Johns Hopkins University, Baltimore, MD

DAVID L. THOMAS, M.D., M.P.H., is Professor of Medicine and Epidemiology at the Johns Hopkins Schools of Medicine and Public Health, and Chief of the Division of Infectious Diseases at the Johns Hopkins School of Medicine. He joined Johns Hopkins in 1993. Dr. Thomas is trained in internal medicine and infectious diseases and cares for patients with chronic viral hepatitis. He also oversees clinical research projects whose aims are focused on understanding the natural history and pathogenesis of hepatitis C virus infection. Liver disease in HIV infected persons is a special area of clinical and research focus. He is the principal investigator on numerous National Institutes of Health grants and the author or co-author of over 140 peer-reviewed publications and holds a U.S. patent. Dr. Thomas serves on numerous editorial and advisory boards and has won international recognition for his academic accomplishments.

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.